Back to Browse Journals » Clinical Interventions in Aging » Volume 3 » Issue 2

Clinical challenges in the management of osteoporosis

Authors Sheryl F Vondracek, Paul Minne, Michael T McDermott

Published Date June 2008 Volume 2008:3(2) Pages 315—329

DOI http://dx.doi.org/10.2147/CIA.S2539

Published 30 June 2008

Sheryl F Vondracek1, Paul Minne2, Michael T McDermott3

1Department of Clinical Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA; 2Amgen Medical Affairs, Denver, CO, USA; 3Director of the Endocrine and Diabetes Practice, Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA

Abstract: While knowledge regarding the diagnosis and treatment of osteoporosis has expanded dramatically over the last few years, gaps in knowledge still exist with guidance lacking on the appropriate management of several common clinical scenarios. This article uses fictional clinical scenarios to help answer three challenging questions commonly encountered in clinical practice. The first clinical challenge is when to initiate drug therapy in a patient with low bone density. It is estimated that 34 million Americans have low bone density and are at a higher risk for low trauma fractures. Limitations of using bone mineral density alone for drug therapy decisions, absolute risk assessment and evidence for the cost-effectiveness of therapy in this population are presented. The second clinical challenge is the prevention and treatment of vitamin D deficiency. Appropriate definitions for vitamin D insufficiency and deficiency, the populations at risk for low vitamin, potential consequences of low vitamin D, and how to manage a patient with low vitamin D are reviewed. The third clinical challenge is how to manage a patient receiving drug therapy for osteoporosis who has been deemed a potential treatment failure. How to define treatment failure, common causes of treatment failure, and the approach to the management of a patient who is not responding to appropriate osteoporosis therapy are discussed.

Keywords: osteoporosis, osteopenia, bisphosphonate, vitamin D, dual-energy X-ray absorptiometry

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease

Sheryl F Vondracek, Norbert F Voelkel, Michael T McDermott, Connie Valdez

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:267-277

Published Date: 13 July 2009

Readers of this article also read:

Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm [Corrigendum]

Tian XH, Wang ZG, Meng H, Wang YH, Feng W, Wei F, Huang ZC, Lin XN, Ren L

International Journal of Nanomedicine 2013, 8:2129-2130

Published Date: 13 June 2013

Current management options for recurrent adrenocortical carcinoma

Glover AR, Ip JCY, Zhao JT, Soon PSH, Robinson BG, Sidhu SB

OncoTargets and Therapy 2013, 6:635-643

Published Date: 6 June 2013

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia

Shao IH, Hou CP, Chen SM, Chen CL, Lin YH, Chang PL, Tsui KH

Clinical Interventions in Aging 2013, 8:431-432

Published Date: 16 April 2013

Dual-channel functional electrical stimulation improvements in speed-based gait classifications

Springer S, Laufer Y, Becher M, Vatine JJ

Clinical Interventions in Aging 2013, 8:271-277

Published Date: 28 February 2013

Concentration- and time-dependent response of human gingival fibroblasts to fibroblast growth factor 2 immobilized on titanium dental implants

Ma Q, Wang W, Chu PK, Mei S, Ji K, Jin L, Zhang Y,

International Journal of Nanomedicine 2012, 7:1965-1976

Published Date: 17 April 2012

Death and dying in the US: the barriers to the benefits of palliative and hospice care

Albert J Finestone, Gail Inderwies

Clinical Interventions in Aging 2008, 3:595-599

Published Date: 5 October 2008

Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans

Farzaneh A Sorond, Lewis A Lipsitz, Norman K Hollenberg, Naomi DL Fisher

Neuropsychiatric Disease and Treatment 2008, 4:433-440

Published Date: 16 April 2008

Candesartan in heart failure

Toni L Ripley, Jennifer S Chonlahan, Robin E Germany

Clinical Interventions in Aging 2006, 1:357-366

Published Date: 22 February 2006